{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:42:38Z","timestamp":1791243758807,"version":"4.1.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T00:00:00Z","timestamp":1343174400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0041786","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T21:17:17Z","timestamp":1343251037000},"page":"e41786","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Cysteinyl Leukotriene Signaling Aggravates Myocardial Hypoxia in Experimental Atherosclerotic Heart Disease"],"prefix":"10.1371","volume":"7","author":[{"given":"Elena","family":"Nobili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Dolores","family":"Salvado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Folkersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Castiglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kastrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Wetterholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tremoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran K.","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Sironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Z.","family":"Haeggstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Gabrielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,7,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1532-5415.1993.tb07457.x","article-title":"Repetitive nocturnal arterial oxygen desaturation and silent myocardial ischemia in patients presenting for vascular surgery.","volume":"41","author":"MD Goldman","year":"1993","journal-title":"J Am Geriatr Soc"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/BF01649418","article-title":"Nocturnal myocardial ischemia and cardiac arrhythmia in patients with sleep apnea with and without coronary heart disease.","volume":"69","author":"U Koehler","year":"1991","journal-title":"Klin Wochenschr"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1378\/chest.111.2.387","article-title":"Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease.","volume":"111","author":"H Schafer","year":"1997","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.05.033","article-title":"Increased urinary leukotriene E4 excretion in obstructive sleep apnea: effects of obesity and hypoxia.","author":"F Stanke-Labesque","year":"2009"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1164\/rccm.201012-2039OC","article-title":"Leukotriene B4 receptor-1 mediates intermittent hypoxia-induced atherogenesis.","volume":"184","author":"RC Li","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1161\/01.CIR.97.24.2406","article-title":"Differential leukotriene constrictor responses in human atherosclerotic coronary arteries.","volume":"97","author":"S Allen","year":"1998","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.85.1.230","article-title":"Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation.","volume":"85","author":"M Carry","year":"1992","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1021\/cr200246d","article-title":"Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease.","volume":"111","author":"JZ Haeggstrom","year":"2011","journal-title":"Chem Rev"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0735-1097(85)80307-7","article-title":"Reduction in blood flow in normal and narrowed coronary arteries of dogs by leukotriene C4.","volume":"6","author":"T Wargovich","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2353\/ajpath.2008.070834","article-title":"Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury.","volume":"172","author":"W Jiang","year":"2008","journal-title":"Am J Pathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.yjmcc.2010.11.013","article-title":"Inhibition of leukotriene C4 action reduces oxidative stress and apoptosis in cardiomyocytes and impedes remodeling after myocardial injury.","volume":"50","author":"UM Becher","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1073\/pnas.96.12.6920","article-title":"Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice.","volume":"96","author":"G Caligiuri","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.neurobiolaging.2004.06.018","article-title":"Cardiovascular functional phenotypes and pharmacological responses in apolipoprotein E deficient mice.","volume":"26","author":"YX Wang","year":"2005","journal-title":"Neurobiol Aging"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa025079","article-title":"Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis.","volume":"350","author":"JH Dwyer","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng1311","article-title":"The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke.","volume":"36","author":"A Helgadottir","year":"2004","journal-title":"Nat Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1073\/pnas.0602414103","article-title":"Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability.","volume":"103","author":"H Qiu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.jacc.2006.12.045","article-title":"Atherosclerosis: the path from genomics to therapeutics.","volume":"49","author":"DT Miller","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng1692","article-title":"A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction.","volume":"38","author":"A Helgadottir","year":"2006","journal-title":"Nat Genet"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nrd1796","article-title":"Leukotriene modifiers as potential therapeutics for cardiovascular disease.","volume":"4","author":"CD Funk","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/cvr\/cvq016","article-title":"The 5-lipoxygenase\/leukotriene pathway in preclinical models of cardiovascular disease.","volume":"86","author":"D Poeckel","year":"2010","journal-title":"Cardiovasc Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1124\/jpet.111.186031","article-title":"A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia\/reperfusion injury and vascular permeability in mice.","volume":"339","author":"NC Ni","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2010.03.140","article-title":"Advances in eicosanoid research, novel therapeutic implications.","volume":"396","author":"JZ Haeggstrom","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00018-002-8463-1","article-title":"Enzymes and receptors in the leukotriene cascade.","volume":"59","author":"JZ Haeggstrom","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"11685","DOI":"10.1073\/pnas.0905364106","article-title":"GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4.","volume":"106","author":"A Maekawa","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"16695","DOI":"10.1073\/pnas.0808993105","article-title":"Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors.","volume":"105","author":"A Maekawa","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.atherosclerosis.2008.07.045","article-title":"Genetic and pharmacological inhibition of the 5-lipoxygenase\/leukotriene pathway in atherosclerotic lesion development in ApoE deficient mice.","volume":"203","author":"RY Cao","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.11.052","article-title":"Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease.","author":"E Ingelsson","year":"2012"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0041786","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T15:46:47Z","timestamp":1540309607000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0041786"}},"subtitle":[],"editor":[{"given":"Christianne Bandeira","family":"de Melo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,25]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0041786","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,25]]}}}